Prasanth Reddy - 17 Feb 2026 Form 3 Insider Report for 20/20 Biolabs, Inc.

Role
Director
Signature
/s/ Prasanth Reddy
Issuer symbol
N/A
Transactions as of
17 Feb 2026
Net transactions value
$0
Form type
3
Filing time
17 Feb 2026, 18:28:38 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reddy Prasanth Director C/O 20/20 BIOLABS, INC., 15810 GAITHER ROAD, SUITE 235, GAITHERSBURG /s/ Prasanth Reddy 17 Feb 2026 0002109266

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding Stock Option 17 Feb 2026 Common Stock 30,000 $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 1, 2024, the Reporting Person was granted a stock option for the purchase of 30,000 shares of common stock, which vested in equal monthly installments over 12 months.